Medical Diagnostics & Clinical Scoring

CHADS2 Score for Atrial Fibrillation Stroke Risk

Use the classic CHADS2 score to assess the risk of stroke in patients with atrial fibrillation to determine the need for anticoagulation.

CHADS2 Score
0
Risk CategoryLow
Annual Stroke Risk1.9%

Calculated locally in your browser. Fast, secure, and private.

Clinical Overview: The CHADS2 Score

The CHADS2 score is a historically significant clinical prediction rule developed to estimate the risk of stroke in patients with non-valvular atrial fibrillation (AF). Atrial fibrillation causes the upper chambers of the heart to quiver rather than beat effectively, which allows blood to pool and potentially form clots. If a clot breaks loose, it can travel to the brain and cause an ischemic stroke.

By standardizing patient evaluation, the CHADS2 score gave clinicians a simple, memorable acronym to rapidly calculate an individual's baseline risk and determine if they require blood-thinning medication.

The Evidence and Pathophysiology

The acronym represents the most critical, independently validated risk factors for stroke:

  • Congestive Heart Failure: A weakened heart struggles to pump blood effectively, increasing the chance of stasis and clot formation.
  • Hypertension: Uncontrolled high blood pressure damages blood vessels and exacerbates endothelial dysfunction.
  • Age > 75: Natural age-related changes in the cardiovascular system inherently increase thrombotic risk.
  • Diabetes Mellitus: Chronic hyperglycemia damages microvasculature and promotes a pro-coagulant state.
  • Stroke/TIA History: Having a prior stroke or transient ischemic attack is the strongest predictor of a future event, earning it a double weighting (2 points).

Formula Breakdown

The scoring system assigns points based on the presence of these conditions:

CHADS2 Score = CHF(1) + HTN(1) + Age>=75(1) + Diabetes(1) + Stroke/TIA(2)

Where:
Max Score=
6 Points
High Risk Threshold=
≥ 2 Points

A score of 0 typically indicated a low risk of stroke (aspirin or no therapy), a score of 1 indicated moderate risk (aspirin or oral anticoagulants), and a score of 2 or higher indicated a high risk warranting immediate oral anticoagulation.

Disclaimer: The CHADS2 score is provided for educational and informational purposes. It has largely been superseded in modern clinical practice by the more nuanced CHA2DS2-VASc score. Never alter your medication regimen without consulting your primary care physician or cardiologist.

Frequently Asked Questions

While groundbreaking when introduced, the CHADS2 score was found to underestimate risk in certain 'low-risk' populations. It did not account for female sex or vascular disease. Modern guidelines universally recommend the CHA2DS2-VASc score instead.

No. A score of 0 indicates a mathematically lower risk (approximately 1.9% per year), but no clinical tool can guarantee immunity from stroke. It simply means the risks of blood thinners (bleeding) may outweigh the benefits of preventing a clot.

No. The CHADS2 score was specifically validated for non-valvular atrial fibrillation. Patients with mechanical valves or moderate-to-severe mitral stenosis inherently require specialized anticoagulation regardless of their score.